$JHX

Singh Jesse G sold $10.3M of JHX (indirect holdings)

Singh Jesse G sold 341,457 indirectly-held shares of James Hardie Industries plc (JHX) at an average of $30.21 ($30.08–$30.34, $10.32M total) across 3 trades over 2026-08-21 to 2026-08-24.

Original reporting
SEC EDGAR · Singh Jesse G
Published Aug 25, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$JHX
Bearish
medium confidence
Mentioned
$JHX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JHXBearishLow
01

Why it matters

The $10.3M sale reduces insider ownership, possibly weakening confidence among shareholders.

02

Market read

Primary relevance is the insider sell; limited broader market effect.

03

What to watch

No 10b5-1 plan; sale may be tax-driven or personal liquidity need.

Relevance 7/10Novelty 5/10Timing: post-market filing on Aug 25, 2026

Background

Form 4 filings disclose insider transactions; director sales are monitored for potential signals.

Company-level read

Ticker impact

$JHXBearishMedium confidence
Context

Director Jesse G. Singh sold 341,457 shares for $10.3M, reducing his stake to 261,683 shares.

Expected impact

Possible short-term downward pressure; watch for 1-2% dip.

Evidence & confidence

Large $10M sale by a director is material; market may interpret as negative sentiment.

Market effects

Minimal impact on building materials sector; may slightly affect peer valuations.

Limited to Australian/UK markets where James Hardie has exposure.

Low global relevance; primarily of interest to investors in JHX.

Counterpoint

Insider sell could be routine diversification, not a red flag.

Key entities

  • James Hardie Industries plc

    Building materials manufacturer listed on NYSE under JHX.

  • Singh Jesse G.

    Director of James Hardie who executed the share sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JHXMed

James Hardie upgrades FY27 cash flow guidance but not earnings, shares dip 5%

James Hardie (JHX) raised its FY27 free cash flow guidance by 20% to ~US$600M, but shares fell 5% as sales and earnings guidance remained unchanged. The company expects to achieve US$125M in cost synergies a year ahead of schedule. Management stated the guidance does not assume a housing recovery. FY26 free cash flow was US$425M, after deal and integration costs of ~US$207M.

$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.